The Swiss diabetes hardware company Ypsomed is selling off its insulin pen needle and blood sugar monitoring operations, as it turns its attention toward its drug autoinjectors and digital insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback